AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9129861
Drug: Vaccines for
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccines for the common cold
Trial: 8456759
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 mg/day, increased to 40 and 80 mg/day at weeks 6 and 12
Trial: 8456759
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg/day, increased to 20 and 40 mg/day at weeks 6 and 12
Trial: 23886644
Drug: S-adenosyl-L-methionine (SAMe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosyl-L-methionine (SAMe) 1.2g daily for 24 weeks
Trial: 23886644
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment and placebo arms combined
Trial: 12717484
Drug: Molsidomine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (8 mg tid)
Trial: 10764316
Drug: 5-lipoxygenase inhibitor
RxNorm normalized name: 5-lipoxygenase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-lipoxygenase inhibitor zileuton
Trial: 9034259
Drug: Intravenous human
RxNorm normalized name: botulism immune globulin IV human Injection [BabyBIG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous human albumin (25 g/day)
Trial: 9034259
Drug: Intravenous human
RxNorm normalized name: botulism immune globulin IV human Injection [BabyBIG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous human albumin
Trial: 31425752
Drug: omega-3 supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omega-3 supplements (3000 mg)
Trial: 31263057
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (81 mg/day)
Trial: 28143522
Drug: Standard-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose aspirin (325 mg/day)
Trial: 18258794
Drug: 0.15 M
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 M hydrochloric acid (HCl) infusion
Trial: 18258794
Drug: 0.075 M
RxNorm normalized name: mestranol 0.075 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 M hydrochloric acid (HCl) infusion
Trial: 18258794
Drug: 0.01 M
RxNorm normalized name: urea 0.01 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 M hydrochloric acid (HCl) infusion
Trial: 16633299
Drug: Oxaliplatin/infusional 5-FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaliplatin/infusional 5-FU combination (OXFU)
Trial: 14761117
Drug: R131 allele
RxNorm normalized name: Human Factor XIII (A2) homodimer (allele F13A*1B), recombinant DNA origin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R131 allele of the FcgammaR IIa polymorphisms in generalized aggressive periodontitis (G-AP)
Trial: 10353936
Drug: Engerix-B vaccine
RxNorm normalized name: Engerix-B
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Engerix-B vaccine administered at 0-, 1-, and 6-month intervals
Trial: 10353936
Drug: Engerix-B vaccine
RxNorm normalized name: Engerix-B
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Engerix-B vaccine administered at 0-, 12-, and 24-month intervals
Trial: 6213349
Drug: 1.0 gm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 gm IV moxalactam every 8 hr for four doses followed by 0.5 gm/kg ethanol
Trial: 26088580
Drug: Web-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based cognitive behavioral therapy (CBT)
Trial: 11155462
Drug: UDCA 300
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 300 mg b.i.d. for twelve months
Trial: 8469914
Drug: atenolol 50/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 50/100 mg od
Trial: 8469914
Drug: hydrochlorothiazide 25/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hydrochlorothiazide 25/50 mg + amiloride 5 mg od (co-amiloride)
Trial: 3512620
Drug: Transdermal electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal electrical nerve stimulation (TENS)
Trial: 24487961
Drug: EMD640744 (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMD640744 (30, 100, and 300 μg doses)
Trial: 20728671
Drug: Drugs group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs group assessments
Trial: 18988286
Drug: 3 courses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 courses of VABEM (vindesine 5 mg/m², doxorubicin 99 mg/m², carmustine 140 mg/m², etoposide 600 mg/m², methylprednisolone 600 mg/m²) followed by low-dose lymph node irradiation
Trial: 18988286
Drug: 4 cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 cycles of ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) followed by myeloablative chemotherapy with carmustine 300 mg/m², etoposide 800 mg/m², cytarabine 1600 mg/m², melphalan 140 mg/m² and autologous stem cell transplantation
Trial: 12792504
Drug: Stable-maintenance CsA
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stable-maintenance CsA dose (control group)
Trial: 7865644
Drug: Enteric coated
RxNorm normalized name: Mesasal Enteric Coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric coated aspirin 300 mg
Trial: 1364978
Drug: ACTH (Synacthen)
RxNorm normalized name: ACTH
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTH (Synacthen) treatment
Trial: 4093902
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of leaflet and tape/slide programme
Trial: 31446803
Drug: Antihypertensive drug
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drug classes (6 classes)
Trial: 10896910
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone with glutamine (mean 0.12 mg/kg/day and oral mean 28 g/day and parenteral mean 5.2 g/day)
Trial: 26888433
Drug: Physical Activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical Activity (PA) intervention consisting of 50-minute center-based exercise 2× weekly, augmented with home-based activity to achieve a goal of 150 min/wk of PA
Trial: 26888433
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education intervention consisting of weekly workshops for 26 weeks, and monthly sessions thereafter
Trial: 25125215
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (70 μg daily for 3 months)
Trial: 9620900
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide (NO) inhalation (7 +/- 1 ppm)
Trial: 9620900
Drug: Aerosolized prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized prostaglandin E1 (PGE1) inhalation (10 +/- 1 ng/kg/min)
Trial: 9620900
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of PGE1 (12 +/- 1 ng/kg/min)
Trial: 1774431
Drug: 5-HT uptake
RxNorm normalized name: 5-HT
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-HT uptake inhibitors (amitriptyline, clovoxamine, fluvoxamine) for 28 days
Trial: 1774431
Drug: Chronic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic treatment with trazodone or maprotiline (weak inhibitors of platelet 5-HT uptake)
Trial: 31665578
Drug: Gilteritinib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gilteritinib (120 mg per day)
Trial: 23478060
Drug: R-BEAM (rituximab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-BEAM (rituximab 375 mg/m² on days -19 and -12, plus carmustine 300 mg/m², etoposide 100 mg/m² twice daily, cytarabine 100 mg/m² twice daily, and melphalan 140 mg/m²)
Trial: 23478060
Drug: B-BEAM (iodine-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-BEAM (iodine-131 tositumomab dosimetric dose of 5 mCi on day -19 and therapeutic dose of 0.75 Gy on day -12, plus carmustine 300 mg/m², etoposide 100 mg/m² twice daily, cytarabine 100 mg/m² twice daily, and melphalan 140 mg/m²)
Trial: 23964468
Drug: Naturopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturopathic treatment
Trial: 23964468
Drug: Orthopaedic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthopaedic treatment
Trial: 19583076
Drug: Lidocaine 1%
RxNorm normalized name: LIDOCAINE 1% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1% (3 mg/kg) + Nitroglycerin (200 microg)
Trial: 17241505
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 microg kg(‐1) bolus 10 min before induction plus 0.5 microg kg(‐1) h(‐1) infusions during maintenance
Trial: 11699169
Drug: Oral chloral
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral chloral hydrate (62.5 mg/kg) with promethazine (12.5 mg)
Trial: 9224438
Drug: Sumatriptan (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (6 mg subcutaneous bolus)
Trial: 9224438
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (800 mg orally)
Trial: 9224438
Drug: L‐Dopa (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐Dopa (500 mg orally)
Trial: 9224438
Drug: GH‐releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH‐releasing hormone (GH‐RH 1 microgram/kg body weight i.v. bolus)
Trial: 8118565
Drug: Cefaclor (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (500 mg) twice daily for 10 days
Trial: 8118565
Drug: Amoxicillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (500 mg) three times daily for 10 days
Trial: 3729164
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg twice daily for 3 days)
Trial: 25120324
Drug: Early prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early prophylactic (EP) pulmonary surfactant therapy
Trial: 25120324
Drug: Late selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late selective (LS) pulmonary surfactant therapy
Trial: 18552688
Drug: Pyridoxalated hemoglobin
RxNorm normalized name: Pyridoxalated hemoglobin polyoxyethylene
DrugBank: Hemoximer (DB17600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridoxalated hemoglobin polyoxyethylene (PHP) at 0.25 mL/kg/hr (20 mg/kg/hr)
Trial: 15780531
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - continuous combined 0.625 mg conjugated equine estrogen plus 2.5 mg/d medoxyprogesterone
Trial: 12413000
Drug: Inspiratory Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory Muscle Training (IMT) - 2 sessions of 10 minutes of training at 30% of PImax, daily for 4 weeks
Trial: 12413000
Drug: Respiratory Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory Muscle Stretch Gymnastics (RMSG) - 3 sessions of 5 RMSG patterns 4 times each, daily for 4 weeks
Trial: 10530772
Drug: Tamoxifen 10
RxNorm normalized name: tamoxifen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10 mg orally, twice daily
Trial: 1746970
Drug: HCFU administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HCFU administration (300-600 mg/day x 12 weeks or more)
Trial: 1746970
Drug: Radical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radical therapy only (Control Group A)
Trial: 6180562
Drug: Flecainide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (400 mg daily)
Trial: 30566416
Drug: L-Methylfolate (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Methylfolate (15 mg)
Trial: 9689270
Drug: Granisetron 2
RxNorm normalized name: granisetron 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 2 mg
Trial: 9689270
Drug: Granisetron 4
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 4 mg
Trial: 9666879
Drug: Alendronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (10 mg orally once daily for 12 months)
Trial: 9666879
Drug: Ketoconazole (200-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200-600 mg orally daily)
Trial: 31325468
Drug: Generic direct-acting
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic direct-acting antivirals (DAAs) with sofosbuvir + ledipasvir ± ribavirin or sofosbuvir + daclatasvir ± ribavirin
Trial: 31325468
Drug: Generic direct-acting
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic direct-acting antivirals (DAAs)
Trial: 25952121
Drug: Combined manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined manual acupuncture and massage therapy (MAMT)
Trial: 25952121
Drug: Manual acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual acupuncture therapy (MAT)
Trial: 24364801
Drug: Behavioral activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral activation (BA) treatment for depression
Trial: 21515198
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy plus either switch to another selective serotonin reuptake inhibitor (SSRI) or switch to venlafaxine
Trial: 21515198
Drug: Switch to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch to another selective serotonin reuptake inhibitor (SSRI)
Trial: 11049707
Drug: Single high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high dose gentamicin (4.5 mg/kg) plus metronidazole (500 mg) preoperatively
Trial: 11049707
Drug: Multiple standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple standard dose gentamicin (1.5 mg/kg) plus metronidazole (500 mg) preoperatively and every 8h for 24h postoperatively
Trial: 8776678
Drug: 0.72 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.72 g/kg (0.9 ml/kg) of ethanol
Trial: 1458013
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of GH plus oxandrolone
Trial: 1458013
Drug: GH alone
RxNorm normalized name: LINER,SECURELY YOURS,PAPER PAK #GH-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH alone and combination therapy
Trial: 3881209
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 micrograms/kg bolus followed by 5 micrograms h‐1 kg‐1 infusion)
Trial: 3881209
Drug: Saline (corresponding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (corresponding volume bolus followed by saline infusion)
Trial: 31101977
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (two unlabeled soft capsules containing 200 μg folic acid each, for 3 months)
Trial: 24909468
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg and Metoclopramide 10 mg (DM group)
Trial: 24909468
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg (MO group)
Trial: 24909468
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg (DO group)
Trial: 20157135
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d
Trial: 17343543
Drug: Oral misoprostol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral misoprostol, 50 microg every 4 h for up to three doses
Trial: 2667758
Drug: metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 100 mg bid for 2 days
Trial: 335924
Drug: Albuterol (170
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (170 micrograms)
Trial: 25487027
Drug: Preservative-free sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free sodium hyaluronate 0.1% and preservative-free fluorometholone 0.1% eyedrops, 4 times a day in the first month and twice a day in the second month.
Trial: 25487027
Drug: Preserved sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops, 4 times a day in the first month and twice a day in the second month.
Trial: 24070809
Drug: VEGF inhibition
RxNorm normalized name: Vegf receptor 2 kinase inhibitor i
DrugBank: VEGFR 2 Kinase inhibitor I (DB17061)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEGF inhibition (anti-VEGF therapy)
Trial: 21651869
Drug: Sevoflurane inhalation
RxNorm normalized name: Sevoflurane Inhalation Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane inhalation anesthesia
Trial: 16772718
Drug: TOTO regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TOTO regimen (4 years alternating treatment and observation, n = 30)
Trial: 16772718
Drug: TTOO regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTOO regimen (2 years treatment followed by 2 years observation, n = 28)
Trial: 11198661
Drug: i.m. vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. vaccine
Trial: 9056064
Drug: Intravenous aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous aminophylline (375 mg)
Trial: 8116453
Drug: Oral dose
RxNorm normalized name: Exactamed Oral Dose Syringe 35cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dose of 100 mg of bisaramil
Trial: 8116453
Drug: Intravenous dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dose of 35 mg of bisaramil
Trial: 10081852
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (40 mg)
Trial: 3086575
Drug: Thiotepa (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiotepa (60 mg)
Trial: 22180582
Drug: Active nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active nicotine (1.0 mcg/kg/min)
Trial: 22180582
Drug: Alcohol (targeted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (targeted breathalyzer of 40 mg% and 80 mg%)
Trial: 19878041
Drug: Acidic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acidic agents (citrate buffer solution, pineapple juice, green mango juice)
Trial: 19878041
Drug: Acidic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acidic agents
Trial: 17712585
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml orange juice and 250 ml blackcurrant juice
Trial: 17712585
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg vitamin E
Trial: 17712585
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml orange juice and 250 ml blackcurrant juice and 15 mg vitamin E
Trial: 10464824
Drug: Codeine phosphate
RxNorm normalized name: Codeine Phosphate
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine phosphate 0.4 mg kg‐1
Trial: 2702016
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg nocte) - Long-term treatment
Trial: 2702016
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg nocte) - Seasonal treatment
Trial: 2702016
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg nocte) - Multicenter trial
Trial: 27483410
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) + etanercept (ETN) combination therapy
Trial: 27483410
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) + sulfasalazine (SSZ) + hydroxychloroquine (HCQ) triple therapy
Trial: 21430116
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (800 μg daily for 3 years)